Sexual functioning in patients with hepatocellular carcinoma

Area of Science:

• Oncology
• Gastroenterology
• Sexual Medicine

Background:

• Hepatocellular carcinoma (HCC) and chronic liver disease (CLD) can impact patient well-being.
• Sexual dysfunction is a potential comorbidity in these patient populations.
• Quality of life (QOL) may be affected by sexual morbidity.

Purpose of the Study:

• To assess sexual dysfunction rates in HCC patients.
• To compare sexual morbidity in HCC patients versus CLD patients and the general population.
• To examine the relationship between sexual dysfunction and QOL in HCC patients.

Main Methods:

• A cohort of 21 men with HCC and 23 men with CLD completed validated questionnaires.
• The Sexual History Questionnaire and Functional Assessment of Cancer Therapy-Hepatobiliary were utilized.
• Patients reported on current sexual problems and met Diagnostic and Statistical Manual of Mental Disorders-4th edition (DSM-IV) criteria for sexual dysfunction.

Main Results:

• 41% of the total sample reported sexual problems; 29% of HCC patients and 71% of CLD patients.
• 43% met DSM-IV criteria for sexual dysfunction (25% HCC, 75% CLD).
• After excluding comorbid conditions and medications, sexual problem rates in HCC patients were comparable to the general population, but QOL was significantly lower for those with sexual problems.

Conclusions:

• While comorbid medical conditions and medications contribute to sexual dysfunction in HCC patients, treatment is still recommended.
• Addressing sexual dysfunction may improve the quality of life for patients with HCC.
• Further research into the specific causes and treatments for sexual dysfunction in HCC is warranted.